我院2012-2014年门诊降糖药类基本药物使用情况分析

发布时间：2018-07-01 12:45

本文选题：降糖药 + 用药频度　；参考：《中国药房》2015年21期

【摘要】：目的:为促进降糖药类基本药物在临床的合理使用提供参考。方法:采用回顾性分析方法,对2012年5月1日-2014年4月30日我院门诊降糖药的销售金额、用药频度(DDDs)、日均费用(DDC)等进行统计并排序、分析。结果:胰岛素和口服降糖药的销售金额及DDDs都呈上升趋势。口服降糖药中销售金额及DDDs排前3位的是阿卡波糖、二甲双胍和格列美脲,胰岛素中DDDs最高的是短效和预混重组人胰岛素,均为2012年版《国家基本药物目录》品种;其余基本药物格列本脲片、格列吡嗪片及中成药DDDs均较小;长效胰岛素类似物DDC明显高于其余种类胰岛素。2012年版《国家基本药物目录》实施后降糖药类基本药物销售比例由10.48%增长到67.78%。结论:我院门诊降糖药物使用基本合理,阿卡波糖和二甲双胍用量最大,胰岛素类似物DDDs增长迅速。
[Abstract]:Objective: to provide reference for the rational use of essential drugs for hypoglycemic drugs. Methods: retrospective analysis was used to analyze the sales amount, DDDs and DDC of hypoglycemic drugs in outpatients of our hospital from May 1, 2012 to April 30, 2014. Results: the sales amount and DDDs of insulin and oral hypoglycemic drugs were on the rise. In oral hypoglycemic drugs, the top 3 places of sales amount and DDDs were acarbose, metformin and glimepiride. The highest DDDs in insulin were short-acting and premixed recombinant human insulin, all of which were the varieties of "National essential drugs catalogue" in 2012; The other essential drugs, glibenclamide tablets, glipizide tablets and Chinese patent medicine DDDs were smaller. DDC of long-acting insulin analogue was significantly higher than that of other kinds of insulin. After the implementation of National essential drugs catalogue in 2012, the sales proportion of essential drugs of hypoglycemic drugs increased from 10.48% to 67.78%. Conclusion: the use of hypoglycemic drugs in outpatient clinic of our hospital is reasonable, the dosage of acarbose and metformin is the largest, and the DDDs of insulin analogues are increasing rapidly.
【作者单位】：首都医科大学附属北京友谊医院药剂科;
【分类号】：R95

【参考文献】